J&J Orthopedics sales drop 5.6% in Q2: 5 key notes

Johnson & Johnson’s orthopedics business reported $2.3 billion in sales for the second quarter.

Advertisement

Here are five key notes:

 

1. Total sales for the orthopedics line were down 5.6 percent over the same period last year.

 

2. United States sales were up 2.1 percent, hitting $1.3 billion last quarter.

 

3. International sales took a huge dip — dropping 14.1 percent — last quarter. International orthopedics sales were $1 billion.

 

4. At the six months in, the orthopedics line reported $4.6 billion worldwide. That’s a 4.7 percent drop from the first half of last year.

 

5. In the first six months of the year, international sales were down 12 percent and United States sales were up 1.7 percent for the orthopedics line.

 

More articles on orthopedic devices:
5 things to know about quality of life after spinal fusion and disc replacement
Surgeon Scorecard—Good or bad for spine? 5 things to know
Neurosurgeon vs. orthopedic spine surgeons: Is there a difference in spinal fusion outcomes? 5 key notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.